Z, D., D, L., N, L., S, L., H, R., J, H., . . . M, H. (2024). CAR-T cells based on a TCR mimic nanobody targeting HPV16 E6 exhibit antitumor activity against cervical cancer. Molecular therapy. Oncology, 32(4), 200892. https://doi.org/10.1016/j.omton.2024.200892
Chicago Style (17th ed.) CitationZ, Duan, Li D, Li N, Lin S, Ren H, Hong J, Hinrichs CS, and Ho M. "CAR-T Cells Based on a TCR Mimic Nanobody Targeting HPV16 E6 Exhibit Antitumor Activity Against Cervical Cancer." Molecular Therapy. Oncology 32, no. 4 (2024): 200892. https://doi.org/10.1016/j.omton.2024.200892.
MLA (9th ed.) CitationZ, Duan, et al. "CAR-T Cells Based on a TCR Mimic Nanobody Targeting HPV16 E6 Exhibit Antitumor Activity Against Cervical Cancer." Molecular Therapy. Oncology, vol. 32, no. 4, 2024, p. 200892, https://doi.org/10.1016/j.omton.2024.200892.